AgomAb
Drug DiscoveryWebsite
Developer of fibrotic disease treatments intended to preserve and restore organ function in fibrotic. The company specializes in growth factor biology and offers treatment that simulates molecular and...
Valuation
$415.6M
Market implied
Share Price
N/A
Total Raised
$334M
Last Round
Later Stage VC (Series C)
Oct 2023
Latest Funding Round
Later Stage VC (Series C)
Oct 11, 2023
$100.7M
raised
Investors
+17 other investors